2009
DOI: 10.3324/haematol.2009.006585
|View full text |Cite
|
Sign up to set email alerts
|

4.1R-deficient human red blood cells have altered phosphatidylserine exposure pathways and are deficient in CD44 and CD47 glycoproteins

Abstract: BackgroundProtein 4.1R is an important component of the red cell membrane skeleton. It imparts structural integrity and has transmembrane signaling roles by direct interactions with transmembrane proteins and other membrane skeletal components, notably p55 and calmodulin. Design and MethodsSpontaneous and ligation-induced phosphatidylserine exposure on erythrocytes from two patients with 4.1R deficiency were studied, using CD47 glycoprotein and glycophorin C as ligands. We also looked for protein abnormalities… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
24
0
2

Year Published

2013
2013
2022
2022

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(27 citation statements)
references
References 55 publications
1
24
0
2
Order By: Relevance
“…Moreover, both spectrin and protein 4.1 have been shown to directly bind to the membrane by fatty acid posttranslational modification [34] and/or association with PS [35,36]. Spectrin is thought to be involved in the formation of large PS-rich lipid domains [35] and protein 4.1-deficient red blood cells show alterations in pathways associated with PS-exposure [37]. Thus it is conceivable that the cytoskeleton is also involved in the regulation of membrane phospholipid asymmetry.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, both spectrin and protein 4.1 have been shown to directly bind to the membrane by fatty acid posttranslational modification [34] and/or association with PS [35,36]. Spectrin is thought to be involved in the formation of large PS-rich lipid domains [35] and protein 4.1-deficient red blood cells show alterations in pathways associated with PS-exposure [37]. Thus it is conceivable that the cytoskeleton is also involved in the regulation of membrane phospholipid asymmetry.…”
Section: Discussionmentioning
confidence: 99%
“…Change in the dynamics of the protein interactions in this complex may affect the expression of the surface marker CD44. By way of example in the erythrocytes from the patients with the genetically caused deficiency of the protein 4.1, the decrease in the CD44 expression was also detected [55]. If one assumes that the attenuation of the interactions in the system of protein macrocomplexes take place in the presence of the cryoprotectants, then the loss of CD44 would increase.…”
Section: Discussionmentioning
confidence: 93%
“…In human erythrocytes, CD44 is able to interact with the cytoskeleton through ankyrin and protein 4.1 [54]. Furthermore, CD44 with another surface marker CD47 are involved in the formation of the macrocomplexes with the involvement of the protein 4.1 [55]. Change in the dynamics of the protein interactions in this complex may affect the expression of the surface marker CD44.…”
Section: Discussionmentioning
confidence: 99%
“…Ці зв'язки є динамічними і можуть відрізнятися в різних ділянках мембрани [3,4]. В еритро-цитах людини виявлена здатність CD44 взає-модіяти з цитоскелетом через анкірин і білок смуги 4.1 [20,21]. Раніше було показано, що зміна білкових взаємодій у макромолеку-лярному комплексі до складу, якого входять білок смуги 4.1 та CD44 може впливати на експресію поверхневого маркера CD44, спри-яючи її зниженню [21].…”
Section: схема дослідуunclassified
“…В еритро-цитах людини виявлена здатність CD44 взає-модіяти з цитоскелетом через анкірин і білок смуги 4.1 [20,21]. Раніше було показано, що зміна білкових взаємодій у макромолеку-лярному комплексі до складу, якого входять білок смуги 4.1 та CD44 може впливати на експресію поверхневого маркера CD44, спри-яючи її зниженню [21]. Якщо припустити, що під впливом факторів середовища в процесі кріоконсервування ослаблюються взаємодії в системі цього макрокомплекса білків, то втрата CD44 буде посилюватися.…”
Section: схема дослідуunclassified